Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-10-31

FDA Approved: TOPIRAMATE — Original Application (Ascend Laboratories, LLC)

View source ↗

Summary

The FDA approved Ascend Laboratories' original ANDA for topiramate, providing a generic version of this anticonvulsant and migraine preventive medicine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate (Topiramate)

Snippet

ORIG AP for TOPIRAMATE (TOPIRAMATE)